{
    "title": "Boehringer launches 81% discounted biosimilar of AbbVie's Humira",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-12586365/Boehringer-launches-81-discounted-biosimilar-AbbVies-Humira.html",
    "date": "2023-10-02",
    "keywords": [
        "version",
        "drug",
        "cyltezo",
        "discount",
        "humira",
        "pbms",
        "price",
        "sunny",
        "boehringer",
        "biosimilar",
        "company",
        "sandoz",
        "amgen",
        "prescription",
        "pagnotta",
        "wingrove",
        "ingelheim",
        "monday",
        "list",
        "blockbuster",
        "rheumatoid",
        "arthritis",
        "july",
        "month",
        "prescriber",
        "food",
        "administration",
        "unit",
        "year",
        "interchangeability",
        "status",
        "fda",
        "compete",
        "biologic",
        "executive",
        "stephen",
        "benefit",
        "insurer",
        "provider",
        "aftermarket",
        "pricing",
        "approach",
        "hyrimoz",
        "healthcare",
        "cigna",
        "optum",
        "rx",
        "market",
        "scrutiny",
        "percentage",
        "incentive",
        "mariam",
        "bengaluru",
        "editing",
        "bill",
        "berkrot"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}